Eli Lilly LLY Rest of world — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's rest of world — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's rest of world — revenue?
- Eli Lilly (LLY) reported rest of world — revenue of $2.77B in Q1 2026.
- How has Eli Lilly's rest of world — revenue changed year-over-year?
- Eli Lilly's rest of world — revenue increased by 177.9% year-over-year, from $997M to $2.77B.
- What is the long-term trend for Eli Lilly's rest of world — revenue?
- Over 3 years (2022 to 2025), Eli Lilly's rest of world — revenue has grown at a 28.5% compound annual growth rate (CAGR), from $2.85B to $6.06B.
- What does rest of world — revenue mean?
- This metric represents the total net sales generated by the company from geographic regions outside of its primary domestic market. It reflects the company's ability to commercialize its pharmaceutical portfolio and expand market share in international territories. Monitoring this figure helps investors assess the geographic diversification of revenue streams and the success of global product launches.